Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jan;19(1):115-22.
doi: 10.1007/s12640-009-9146-6. Epub 2009 Dec 29.

Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy

Affiliations
Comparative Study

Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy

D L Pountney et al. Neurotox Res. 2011 Jan.

Abstract

Multiple system atrophy (MSA) is an adult-onset neurodegenerative disease characterised by Parkinsonian and autonomic symptoms and by widespread intracytoplasmic inclusion bodies in oligodendrocytes. These glial cytoplasmic inclusions (GCIs) are comprised of 9-10 nm filaments rich in the protein alpha-synuclein, also found in neuronal inclusion bodies associated with Parkinson's disease. Metallothioneins (MTs) are a class of low-molecular weight (6-7 kDa), cysteine-rich metal-binding proteins the expression of which is induced by heavy metals, glucocorticoids, cytokines and oxidative stress. Recent studies have shown a role for the ubiquitously expressed MT-I/II isoforms in the brain following a variety of stresses, whereas, the function of the brain-specific MT isoform, MT-III, is less clear. MT-III and MT-I/II immunostaining of post-mortem tissue in MSA and normal control human brains showed that the number of MT-III-positive cells is significantly increased in MSA in visual cortex, whereas MT-I/II isoforms showed no significant difference in the distribution of immunopositive cells in MSA compared to normal tissue. GCIs were immunopositive for MT-III, but were immunonegative for the MT-I/II isoforms. Immunofluorescence double labelling showed the co-localisation of alpha-synuclein and MT-III in GCIs in MSA tissue. In isolated GCIs, transmission electron microscopy demonstrated MT-III immunogold labelling of the amorphous material surrounding alpha-synuclein filaments in GCIs. High-molecular weight MT-III species in addition to MT-III monomer were detected in GCIs by Western analysis of the detergent-solubilised proteins of purified GCIs. These results show that MT-III, but not MT-I/II, is a specific component of GCIs, present in abnormal aggregated forms external to the alpha-synuclein filaments.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Neuropathol Exp Neurol. 2004 Jan;63(1):43-52 - PubMed
    1. J Neurochem. 2008 Jan;104(1):14-20 - PubMed
    1. Toxicol Appl Pharmacol. 2008 Sep 15;231(3):318-27 - PubMed
    1. Biochem Biophys Res Commun. 2008 May 2;369(2):666-71 - PubMed
    1. J Neurosci Res. 2006 May 1;83(6):974-84 - PubMed

Publication types

LinkOut - more resources